WHC is still in active development. Read this to understand our approach.
depiction of PXDBZSCGSQSKST-UHFFFAOYSA-N.svg
isomerdesign

Etonitazene

Verificar en isomerdesign

drugmap

ETONITAZENE

Verificar en drugmap

wiki

Etonitazene

Verificar en wiki

Data

InChI: InChI=1S/C22H28N4O3/c1-4-24(5-2)13-14-25-21-12-9-18(26(27)28)16-20(21)23-22(25)15-17-7-10-19(11-8-17)29-6-3/h7-12,16H,4-6,13-15H2,1-3H3

Sinónimos: C22H28N4O3, ARC 1G2, Etonitazinum, NIH 7607, UNII-9U3GT3353T, Etobedolum, Etonitazeno [INN-Spanish],Etonitazene, Etonitazene [INN:BAN:DCF], PXDBZSCGSQSKST-UHFFFAOYSA-N, 911-65-9, Etonitazenum [INN-Latin], 1-(2-Diethylaminoethyl)-2-(p-ethoxybenzyl)-5-nitrobenzimidazole, EINECS 213-009-1, 9U3GT3353T, Ba 20684, BRN 0363324, 1-(2-(Diethylamino)ethyl)-2-(p-ethoxybenzyl)-5-nitrobenzimidazole, DEA No. 9624, CHEMBL312040, Etonitazine, 1H-Benzimidazole-1-ethanamine, 2-((4-ethoxyphenyl)methyl)-N,N-diethyl-5-nitro-, Ba-20684,N-[2-[2-[(4-Ethoxyphenyl)methyl]-5-nitro-benzoimidazol-1-yl]ethyl]-N-ethyl-ethanamine, Ciba 20-684BA

Estimated data

Solubilidad: -5.361 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 80.0% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.